| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 06/01/2011 | CN102083457A Smallpox DNA vaccine and the antigens therein that elicit an immune response |
| 06/01/2011 | CN102083456A Neurodegenerative disorders |
| 06/01/2011 | CN102083419A Pharmaceutical composition containing surface-coated microparticles |
| 06/01/2011 | CN102083412A Programmed-release, nanostructured biological construct for stimulating cellular engraftment for tissue regeneration |
| 06/01/2011 | CN102080074A Construction and application of porcine circovirus type II-porcine mycoplasma pneumoniae expressing strains |
| 06/01/2011 | CN102079787A Antihuman CD52 engineering antibody, carrier, kit and application thereof |
| 06/01/2011 | CN102079785A Thymopoietin-II mutant |
| 06/01/2011 | CN102079783A Japanese blood fluke protein and application thereof |
| 06/01/2011 | CN102078613A Inhibitors of her3 activity |
| 06/01/2011 | CN102078609A Method for preparing duck virus hepatitis refined heterogenous yolk antibody |
| 06/01/2011 | CN102078608A Formulation of human antibodies for treating tnf-alpha associated disorders |
| 06/01/2011 | CN102078607A Preparation and application of recombinant adenovirus vector bivalent living vaccine for herpes progenitalis |
| 06/01/2011 | CN102078606A Respiratory syncytial virosome vaccine and preparation method thereof |
| 06/01/2011 | CN102078605A Method for preparing Vero cell influenza virus vaccine |
| 06/01/2011 | CN102078604A Meningococcus capsular polysaccharide polyvalent multivalent conjugate vaccine, preparation method and application thereof |
| 06/01/2011 | CN102078597A Methods for treating muscle injuries |
| 06/01/2011 | CN101603024B Porcine mycoplasmal pneumonia and porcine infectious actinobacillus pleuropneumoniae serum 1 type gene engineering strain vaccine and application thereof |
| 06/01/2011 | CN101381402B NY-ESO-1 tumour antigen mimic epitope and use thereof |
| 06/01/2011 | CN101362795B Epitope of epididymal protease inhibitor B cell and antigen peptides containing thereof |
| 06/01/2011 | CN101348521B Aminoacid mimic epitope of human B lymphocyte stimulating factor receptor and use thereof |
| 06/01/2011 | CN101230334B Herpes simplex virus and recombinant virus as well as host cell and medicinal combination thereof |
| 06/01/2011 | CN101204581B Real time individual poultry and eggs antibody preparation for AIDS virus, preparation method and application thereof |
| 05/31/2011 | US7951921 Multivalent carriers of bi-specific antibodies |
| 05/31/2011 | US7951920 Conjugate of an antibody against CCR5 and an antifusogenic peptide |
| 05/31/2011 | US7951919 TACI-immunoglobulin fusion proteins |
| 05/31/2011 | US7951918 Stabilized polypeptide compositions |
| 05/31/2011 | US7951917 Method for making multispecific antibodies having heteromultimeric and common components |
| 05/31/2011 | US7951909 A polypeptide containing an N-terminal fragment of Amyloid beta (A beta ) peptide linked to a helper T cell epitope (Th) having multiple class II binding motifs; generated antibodies are highly cross-reactive to the soluble A beta 1-42 peptide and the amyloid plaques in the brain |
| 05/31/2011 | US7951907 Circovirus sequences associated with piglet weight loss disease (PWD) |
| 05/31/2011 | US7951904 Therapeutic uses of monoclonal antibodies to the angiotensin-II type-1 receptor |
| 05/31/2011 | US7951785 NFIA in glial fate determination, glioma therapy and astrocytoma treatment |
| 05/31/2011 | US7951781 Methods and compositions related to PLUNC surfactant polypeptides |
| 05/31/2011 | US7951775 Methods and pharmaceutical compositions for GnRH-I and GnRH-II modulation of T-cell activity, adhesion, migration and extravasation |
| 05/31/2011 | US7951770 Peptides, peptidomimetics and small molecule inhibitors of the Epstein-Barr virus mediated fusion and entry process |
| 05/31/2011 | US7951614 Methods and compositions for the production of monoclonal antibodies |
| 05/31/2011 | US7951587 Recombinant mononegaviral virus vectors |
| 05/31/2011 | US7951585 Construction of oncolytic adenovirus recombinant specifically expressing immune modulatory factor GM-CSF in tumor cells and uses thereof |
| 05/31/2011 | US7951546 Compositions and methods for the diagnosis and treatment of tumor |
| 05/31/2011 | US7951531 Flavivirus NS5A proteins for the treatment of HIV |
| 05/31/2011 | US7951386 Recombinant cytochrome oxidase and/or morula membrane protein for use in developing therapeutics which prevent infection associated with mite parasitfes |
| 05/31/2011 | US7951385 Probiotic strain and antimicrobial peptide derived therefrom |
| 05/31/2011 | US7951384 Virus-like particles as vaccines for paramyxovirus |
| 05/31/2011 | US7951383 Attenuated parainfluenza virus (PIV) vaccines |
| 05/31/2011 | US7951380 Methods of stimulating bone growth using ZVEGF4 polypeptides |
| 05/31/2011 | US7951379 Hollow nanoparticle of NBsAg large protein for drug delivery |
| 05/31/2011 | US7951378 Modified cell adhesion molecule comprising immunoglobulin heavy chain fusion for treatment and prevention of respiratory system disorders |
| 05/31/2011 | US7951377 Mosaic clade M human immunodeficiency virus type 1 (HIV-1) envelope immunogens |
| 05/31/2011 | US7951376 Multimeric complexes of antigens and an adjuvant |
| 05/31/2011 | US7951375 Methods of inducing an immune response |
| 05/31/2011 | US7951374 Methods for inhibiting STAT3 signaling in immune cells |
| 05/31/2011 | US7951373 Administering to mammal a neural growth and/or remyelination and/or neuroprotection promoting amount of an agent comprising a neural cell adhesion molecule, which molecule is capable of overcoming inhibitory molecular cues found on glial cells |
| 05/31/2011 | US7951372 Method of treating psoriasis by administering IL-22 antibodies, or binding fragments thereof |
| 05/31/2011 | US7951371 Soluble lymphotoxin-β receptor fusion protein and methods for inhibiting lymphotoxin β-receptor signaling |
| 05/31/2011 | US7951370 Anti-TYRP1 antibodies |
| 05/31/2011 | US7951369 Chimeric, human and humanized anti-granulocyte antibodies and methods of use |
| 05/31/2011 | US7951368 Compositions of specific binding agents to hepatocyte growth factor |
| 05/31/2011 | US7951361 Transgenic escherichia for which express bacterial surface protein for use in generation of vaccine which prevents coliform bacterial infection; antidiarrhea agents |
| 05/31/2011 | CA2539168C Optimized expression of hpv 45 l1 in yeast |
| 05/31/2011 | CA2451626C One dose vaccination with mycoplasma hyopneumoniae |
| 05/31/2011 | CA2438108C Improved drug formulation of soluble glass particles suspended in a liquid |
| 05/31/2011 | CA2400929C Antagonistic selective binding agents of osteoprotegerin binding protein |
| 05/31/2011 | CA2398929C Neuroprotective, antithrombotic and anti-flammatory uses of activated protein c (apc) |
| 05/31/2011 | CA2339324C Protein delivery system using human papillomavirus virus-like particles |
| 05/31/2011 | CA2321903C Live recombinant vaccines comprising an adjuvant compound and a viral vector comprising a gene of an animal herpes or influenza virus |
| 05/31/2011 | CA2319080C Multivalent antibacterial agents |
| 05/31/2011 | CA2301942C Molecular mimetics of meningococcal b epitopes |
| 05/31/2011 | CA2215328C Novel human cytomegalovirus dna sequences |
| 05/26/2011 | WO2011063359A1 Compositions, methods and uses for poxvirus elements in vaccine constructs |
| 05/26/2011 | WO2011063346A1 Targeting of the c-terminal segment of c. difficile toxin b for improved clinical diagnosis, prevention, and treatment |
| 05/26/2011 | WO2011063277A1 Anti-orai1 antigen binding proteins and uses thereof |
| 05/26/2011 | WO2011063263A2 Methods for producing an immune response to tuberculosis |
| 05/26/2011 | WO2011063237A2 Jagged-binding agents and uses thereof |
| 05/26/2011 | WO2011063198A2 Methods and compositions for modulating the activity of the interleukin-35 receptor complex |
| 05/26/2011 | WO2011063161A2 Epithelial membrane protein-2 (emp2) and proliferative vitreoretinopathy (pvr) |
| 05/26/2011 | WO2011063133A1 LOW ANTIGEN-DOSE IMMUNIZATION FOR MAXIMIZING T-HELPER CELL 1 (T h1) IMMUNITY AGAINST DISEASE |
| 05/26/2011 | WO2011063127A1 Targeting tumor cells with chemotherapeutic agents conjugated to matriptase antibodies |
| 05/26/2011 | WO2011062786A2 Compounds and methods for inhibiting the metastasis of cancer cells |
| 05/26/2011 | WO2011062637A1 Enhanced malaria msp-1 subunit vaccine |
| 05/26/2011 | WO2011062615A1 Biosynthetic system that produces immunogenic polysaccharides in prokaryotic cells |
| 05/26/2011 | WO2011062562A1 Hepatitis b virus specific antibody and uses thereof |
| 05/26/2011 | WO2011062560A1 Method for producing t cell receptor-like monoclonal antibodies and uses thereof |
| 05/26/2011 | WO2011062263A1 Pharmaceutical composition |
| 05/26/2011 | WO2011062112A1 Highly-functional mutant of humanized anti-egfr antibody variable region |
| 05/26/2011 | WO2011061849A1 Recombinant measles virus useful as bivalent vaccine against measles and nipah virus infection |
| 05/26/2011 | WO2011061848A1 Recombinant measles virus useful as bivalent vaccine against measles and malaria infection |
| 05/26/2011 | WO2011061712A1 Formulations of antibody |
| 05/26/2011 | WO2011061454A1 Use of polyvalent immunoglobulins for treating alcoholic or metabolic liver cirrhosis |
| 05/26/2011 | WO2011061119A1 Humanized antibodies against human il-22ra |
| 05/26/2011 | WO2011039639A3 Jfh-1 based hcv cell culture systems for ns5a of genotypes 1-7 |
| 05/26/2011 | WO2011039180A3 Novel vaccine composition against influenza |
| 05/26/2011 | WO2011038397A3 Peptide adjuvants, vaccines, and methods of use |
| 05/26/2011 | WO2011016026A3 Novel proteins |
| 05/26/2011 | WO2011014872A3 Compositions and methods for diagnosing, treating or preventing neoplasias |
| 05/26/2011 | WO2011009042A3 Antigen compositions and methods of inhibiting campylobacter jejuni bacterial infection and uses of the antigen compositions |
| 05/26/2011 | WO2011008092A3 Gram-positive bacteria specific binding compounds |
| 05/26/2011 | WO2010144711A3 Immunological targeting of pathological tau proteins |
| 05/26/2011 | WO2010137036A3 Japanese encephalitis vaccine and method of manufacturing the same |
| 05/26/2011 | WO2010136311A3 Compositions and methods for antibodies targeting complement protein c3b |
| 05/26/2011 | WO2010120541A3 Compositions and methods for modulating the activity of complement regulatory proteins on target cells |
| 05/26/2011 | WO2010118424A3 Papillomavirus-like particles (vlp) as broad spectrum human papillomavirus (hpv) vaccines |